Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for…
Biotechnology
US, Pasadena [HQ]
ARWR/Financial Reporting
Income Statements
15 Sheets · Starting from 2009In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.00 | - - | - - | - - | - - | - - | - - | - - | 31.00 | 16.00 | 168.00 | 87.00 | 138.00 | 243.00 | 240.00 | |
|
EPS
|
-4.27 | -0.90 | -0.44 | -1.90 | -1.30 | -1.25 | -1.60 | -1.34 | -0.47 | -0.65 | 0.72 | -0.84 | -1.36 | -1.67 | -1.92 | |
| Diluted in mil. | -4.27 | -0.90 | -0.44 | -1.90 | -1.30 | -1.25 | -1.60 | -1.34 | -0.47 | -0.65 | 0.69 | -0.84 | -1.36 | -1.67 | -1.92 | |
|
Profit
|
3.00 | - - | - - | - - | - - | - - | - - | - - | 31.00 | 16.00 | 168.00 | 87.00 | 138.00 | 232.00 | 228.00 | |
| Gross Margin | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 95.72 | 94.81 | |
| Pre Tax | -19.00 | -7.00 | -8.00 | -22.00 | -31.00 | -58.00 | -91.00 | -81.00 | -34.00 | -54.00 | 68.00 | -84.00 | -140.00 | -172.00 | -206.00 | |
| Profit Margin | -507.73 | -1,183.10 | -2,966.52 | -15,054.05 | -10,922.08 | -33,554.35 | -24,067.67 | -51,613.12 | -109.46 | -337.30 | 40.37 | -96.09 | -101.85 | -71.01 | -85.78 | |
| ETR | -0.28 | 44.27 | 78.14 | 0.92 | -19.63 | -0.01 | - - | - - | -0.01 | - - | 0.25 | - - | - - | -2.19 | -1.35 | |
| Net | -19.00 | -5.00 | -3.00 | -21.00 | -31.00 | -58.00 | -91.00 | -81.00 | -34.00 | -54.00 | 67.00 | -84.00 | -140.00 | -176.00 | -205.00 | |
| Profit Margin | -511.73 | -931.15 | -1,056.56 | -14,383.61 | -10,729.22 | -33,502.97 | -24,068.29 | -51,614.64 | -109.46 | -337.32 | 40.27 | -96.09 | -101.85 | -72.56 | -85.27 | |
| EBITDA | -18.00 | -9.00 | -10.00 | -18.00 | -14.00 | -41.00 | -96.00 | -74.00 | -33.00 | -51.00 | 65.00 | -87.00 | -140.00 | -178.00 | -188.00 | |
| EBITDA Margin | -499.08 | -1,585.65 | -3,607.83 | -12,611.40 | -5,114.27 | -23,710.47 | -25,268.65 | -46,787.48 | -105.69 | -320.08 | 38.88 | -99.12 | -101.79 | -73.39 | -78.16 | |
| Operating Income | -19.00 | -8.00 | -9.00 | -21.00 | -24.00 | -53.00 | -95.00 | -81.00 | -36.00 | -55.00 | 61.00 | -93.00 | -149.00 | -178.00 | -205.00 | |
| Operating Margin | -522.87 | -1,419.46 | -3,319.48 | -14,358.61 | -8,471.29 | -30,443.59 | -25,124.08 | -51,627.09 | -117.79 | -346.52 | 36.25 | -105.87 | -107.77 | -73.39 | -85.16 | |
| Interest Income | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 6.00 | 9.00 | 6.00 | 5.00 | 15.00 | |
| Loss | -23.00 | -9.00 | -10.00 | -21.00 | -23.00 | -51.00 | -96.00 | -79.00 | -68.00 | -72.00 | -107.00 | -181.00 | -287.00 | -421.00 | -445.00 | |
| Cost of Revenue | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -10.00 | -12.00 | |
|
Operating Expenses
|
-23.00 | -9.00 | -10.00 | -21.00 | -23.00 | -51.00 | -96.00 | -79.00 | -68.00 | -72.00 | -107.00 | -181.00 | -287.00 | -421.00 | -445.00 | |
| R&D | -8.00 | -1.00 | -3.00 | -5.00 | -8.00 | -23.00 | -57.00 | -41.00 | -31.00 | -52.00 | -81.00 | -128.00 | -206.00 | -297.00 | -353.00 | |
| G&A | -14.00 | -7.00 | -5.00 | -14.00 | -11.00 | -24.00 | -34.00 | -40.00 | -32.00 | -19.00 | -26.00 | -52.00 | -80.00 | -124.00 | -92.00 | |
| SG&A | -14.00 | -7.00 | -5.00 | -14.00 | -11.00 | -24.00 | -34.00 | -40.00 | -32.00 | -19.00 | -26.00 | -52.00 | -80.00 | -124.00 | -92.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Depreciation and Amortization | - - | - - | - - | -1.00 | -1.00 | -1.00 | -2.00 | -3.00 | -4.00 | -4.00 | -4.00 | -5.00 | -8.00 | -10.00 | -12.00 | |
| Interest Expenses | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -6,957.00 | -9,190.00 | -6.00 | -5.00 | -18.00 | |
| Other Expenses | - - | -1.00 | - - | -1.00 | -8.00 | -8.00 | -3.00 | -2.00 | -2.00 | - - | -6.00 | -8.00 | -8.00 | -5.00 | -1.00 | |
|
WA Shares Outstanding
|
4.00 | 6.00 | 7.00 | 11.00 | 23.00 | 46.00 | 57.00 | 60.00 | 73.00 | 83.00 | 93.00 | 100.00 | 103.00 | 105.00 | 106.00 | |
| Diluted | 4.00 | 6.00 | 7.00 | 11.00 | 24.00 | 46.00 | 57.00 | 61.00 | 73.00 | 83.00 | 98.00 | 100.00 | 103.00 | 105.00 | 106.00 |